MEETINGS - Annual Oak Ridge Conference (US) April 2008
This article was originally published in Clinica
The 40th Annual Oak Ridge Conference - Breakthrough Technologies for Clinical Diagnostics, to be held in San Jose, California from April 17-18, is dedicated to exploring emerging technologies for the clinical laboratory. According to a survey of past presenters conducted by the American Association of Clinical Chemistry (AACC), 80% of the technologies presented at past Oak Ridge Conferences were successfully launched onto the market. The conference programme features a keynote presentation, invited speakers, oral presentations, and a poster session. There will also be opportunities for networking and discussion with scientists from academia and industry who are developing a wide range of technologies for diagnostic testing. To register contact the AACC on tel: +1 202 857 0717.
You may also be interested in...
Public Company Edition: Lixte’s small uplisting was the only biopharma initial public offering in the US during Thanksgiving week, but IPOs are ramping up again. Also, LifeSci launched its second SPAC and in follow-on offerings Reata brought in $281m and Intellia grossed $175m.
Orladeyo is the first oral prophylactic approved in the US for hereditary angioedema, with Japan and EU approvals expected to follow. Pricing of $485,000 a year undercuts segment leader.
Results of Study to Assess Statin Residual Risk with Epanova in High Cardiovascular Risk Patients with Hypertriglyceridemia “should prompt reconsideration of [OTC] mixed omega-3 fatty acid products for [atherosclerotic cardiovascular disease] prevention,” say cardiologists in an editorial published with JAMA study.